Cell-mediated effector molecules and complicated malaria

International Archives of Allergy and Immunology

Volumn 137, Issue 4, 2005, Pages 326-342

  Nyangoto, Evans O ^a  

^a JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

Author keywords

Cerebral malaria; Immune complexes; Interleukin 10; Leukocytes; Nitric oxide; Plasmodium falciparum; Reactive oxygen intermediates; Recruitment; Sequestration; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 10; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TOXIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANTIGEN ANTIBODY COMPLEX; BRAIN MALARIA; CELL STIMULATION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; GROWTH INHIBITION; HOST; HUMAN; HYPERLACTATEMIA; HYPOGLYCEMIA; INFLAMMATION; LEUKOCYTE; MALARIA; MEDIATOR; MOLECULE; MONONUCLEAR PHAGOCYTE; NONHUMAN; PARASITE; PARASITE DEVELOPMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 23844468432     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086490     Document Type: Review

References (166)

1. World Health Organization (WHO): African Malaria Report, 2003.
2. Stanley J: Malaria. Emerg Med Clin North Am 1997;15:113-155.
3. Robbins R, Cotran S, Tucker VK, Stanley C, Robbins L, Schmitt B: Pathologic Basis of Disease, ed 6. New York, Saunders, 1999.
4. Cottrell BJ: Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol 1978;34:147.
5. Clark IA: Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet 1978;ii:75-77.
6. Clark IA, Virelizier JL, Carswell EA, Wood PR: Possible importance of macrophage-derived mediators in malaria. Infect Immun 1981;32:1058-1066.
7. Clark IA: Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klin Wochenschr 1982;60:756-758.
8. Clark IA: Cell-mediated immunity in protection and pathology of malaria. Parasitol Today 1987;3:300-305.
9. Spriggs DR, Sherman ML, Michie H, Arthur KA, Imura K, Wilmore D, Frei E, Kufe DW: Recombinant tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. J Natl Cancer Inst 1988;80:1039-1044.
10. Butcher GA, Garland T, Adjuckiewicz AB, Clark IA: Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands. Trans R Soc Trop Med Hyg 1990;85:658-661.
11. Grau GE, Piquet PF, Vassalli P, Lambert PH: Tumor necrosis factor and other cytokines in cerebral malaria. Experimental and clinical data. Immunol Rev 1989;112:49-70.
12. Kern P, Hemmer CJ, Van Damme J, Grass HJ, Dietrich M: Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 1989;87:139-143.
13. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane K, Monogue R, Cerami AD, Greenwood BM: TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated P. falciparum malaria. Lancet 1990;336:1201-1204.
14. Bate CA, Taverne J, Playfair JH: Malarial parasites induce TNF production by macrophages. Immunology 1988;64:227-231.
15. Schofield L, Hackett F: Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med 1993;177:145-153.
16. Carswell EA, Old LJS, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-3670.
17. Manel DN, Moore RN, Mergenhagen SE: Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun 1980;30:523-530.
18. Degliantoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G: Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med 1985;162:1512-1530.
19. Paya CV, Kenmotsu N, Schoon RA, Leibson PJ: Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J Immunol 1988;141:1989-1995.
20. Richards AL, Dennert G, Pluznik DH, Takagaki Y, Djeu JY: Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor. Nat Immun Cell Growth Regul 1989;8:76-88.
21. Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DTW, Gordon JR, Dvorak AM, Weller PF, Galli SJ: Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest 1993,91:2673-2684.
22. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 1989;170:827-845.
23. Haranaka K, Sateomi N, Sakurai A: Antitumor activity of murine tumor necrosis factor against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 1984;34:263-267.
24. Feinman R, Heriken-DeStafano D, Tsujimoto M: TNF is an important mediator of tumor cell killing by human monocytes. J Immunol 1987;138:635-640.
25. Tomazic VJ, Farha M, Loftus A, Elias EG: Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro. J Immunol 1988;140:4056-4061.
26. Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsin H, Miller LH, Good MF, Milon G: Malaria pathogenesis. Science 1994;264:1878-1883.
27. Silberstein DS, David JR: Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci USA 1986;83:1055.
28. Esparza I, Mannel D, Kuppel A, Falk W, Krammer PH: Interferon gamma and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni. J Exp Med 1987;166:589-594.
29. Liew F, Li Y, Millot S: Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990;145:4306-4310.
30. Djeu JY, Blanchard DK, Halkias D, Friedman H: Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: Activation by interferon-gamma and tumor necrosis factor. J Immunol 1986;137:2980-2984.
31. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, O'Connor JV: Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 1986;163:1433-1450.
32. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, Greenwood BM: Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 1993;86:91-98.
33. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH: Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989;320:1586-1591.
34. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassali P: Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.. Science 1987;237:1210-1212.
35. Knowles RG, Moncada S: Nitric oxide synthase in mammals. Biochem J 1994;298:249-258.
36. Morris SM Jr, Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994;266:E829-E839.
37. Nathan CF, Hibbs JB Jr: Role of nitric oxide synthesis in macrophage antimicrobial activity (review). Curr Opin Immunol 1991;3:65-70.
38. Sessa WC: The nitric oxide synthase family of proteins. J Vasc Res 1994;31:131-143.
39. Stuehr DJ, Griffith OW: Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 1992;65:287-346.
40. Moncada S, Palmer RM, Higgs EA: Biosynthesis of nitric oxide from L-arginine: A pathway for the regulation of cell function and communication. Biochem Pharmacol 1989;38:1709-1715.
41. Moncada S, Higgs EA: The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
42. Garthwaite J: Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci 1991;14:60-67.
43. Snyder SH, Bredt DS: Biological roles of nitric oxide. Sci Am 1992;266:68-71.
44. Murad F, Ishii K, Forstermann U, Gorsky L, Kerwin JF Jr, Pollock J, Heller M: EDRF is an intracellular second messenger and autacoid to regulate cyclic GMP synthesis in many cells. Adv Second Messenger Phosphoprotein Res 1990;24:441-448.
45. Ignarro LJ: Heme-dependent activation of guanylate cyclase by nitric oxide: A novel signal transduction mechanism. Blood Vessels 1991;28:67-73.
46. Nussler AK, Eling W, Kremsher PG: Patients with Plasmodium falciparum malaria and Plasmodium vivax malaria show increased nitrite and nitrate plasma levels. J Infect Dis 1994;169:1418-1419.
47. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM: Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87-94.
48. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS: Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 1988;27:8706-8711.
49. Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF: Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med 1989;169:1011-1020.
50. Hibbs JB Jr, Taintor RR, Vavrin Z, Granger DL, Drapier JC, Amber IJ, Lancaster JR Jr: Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron; in Moncada S, Higgs EA (eds): Nitric Oxide from L-Arginine: A Bioregulatory System. Amsterdam, Elsevier, 1990, pp 189-223.
51. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR: DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89:3030-3034.
52. Madaio MP: The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol 1999;19:48-56.
53. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D: From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999;10:451-461.
54. Bolton WK: Goodpasture's syndrome (review). Kidney Int 1996;50:1753-1766.
55. Ando M, Suga M: Hypersensitivity pneumonitis. Curr Opin Pulm Med 1997;3:391-395.
56. Dugas B, Mossalayi MD, Damais C, Kolb JP: Nitric oxide production by human monocytes: Evidence for a role of CD23. Immunol Today 1995;16:574-580.
57. Voldoukis I, Issaly F, Fourcade C, Paul-Eugene N, Arock M, Kolb JP, da Silva AO, Monjour L, Poinsot H, Tselentis Y, Dugas B, Debre P, Mossalayi MD: CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: possible role in monocyte activation. Res Immunol 1994;145:17-27.
58. Perlmann P, Perlmann H, Flyg BW, Hagstedt M, Elghazali G, Worku S, Fernandez V, Rutta AM, Troye-Blomberg M: Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria. Infect Immun 1997;65:116-121.
59. Perlmann P, Perlmann H, ElGhazali G, Troye-Blomberg M: IgE and tumor necrosis factor in malaria infection (review). Immunol Lett 1999;65:29-33.
60. Perlmann H, Helmby H, Hagstedt M, Carlson J, Larsson PH, Troye-Blomberg M, Perlmann P: IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: Association of high IgE levels with cerebral malaria. Clin Exp Immunol 1994;97:284-292.
61. Clark IA, Hunt NH: Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun 1983;39:1-6.
62. Ockenhouse CF, Schulman S, Shear HL: Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J Immunol 1984;133:1601-1608.
63. Wozencraft AO, Dockrell HM, Taverne J, Targett GA, Playfair JH: Killing of human malaria parasites by macrophage secretory products. Infect Immun 1984;43:664-669.
64. Lunel F, Druilhe P: Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect Immun 1989;57:2043-2049.
65. Jones KR, Cottrell BJ, Targett GA, Playfair JHL: Killing of Plasmodium falciparum by human monocyte-derived macrophages. Parasite Immunol 1989;11:585-592
66. Trager W, Jensen JB: Human malaria parasites in continuous culture. Science 1976;193:673-675.
67. Allison AC, Eugui EM: The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress. Annu Rev Immunol 1983;1:361-392.
68. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
69. Brown H, Turner G, Rogerson S, Tembo M, Mwenechanya J, Molyneux M, Taylor T: Cytokine expression in the brain in human cerebral malaria. J Infect Dis 1999;180:1742-1764.
70. Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello C A, Greenwood B: Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol 1989;77:361-366.
71. De Kossodo S, Grau GE: Role of cytokines and adhesion molecules in malaria immunopathology. Stem Cells 1993;11:41-48.
72. Sporn MB, Roberts AB, Wakefield LM, Crombugghe B: Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol 1987;105:1039-1045.
73. Oo MM, Aikawa M, Than T, Aye TM, Myint PT, Igarshi I, Schoene WC: Human cerebral malaria: A pathological study. J Neuropathol Exp Neurol 1987;46:223-231.
74. World Health Organization (WHO). Trends in health. World Health Stat Q 1995;48:192.
75. Aikawa M, Iseki M, Barnwell JW, Taylor D, Oo MM, Howard R: The pathology of human cerebral malaria. Am J Trop Med Hyg 1990;43:30-37.
76. Miller LH, Good MF, Milon G: Malaria pathogenesis. Science 1994;264:1878-1883.
77. Azizul H, Echchannaoui H, Seguin R, Schwartzman J, Kasper HL, Haque S: Cerebral malaria in mice: IL-2 treatment induces accumulation of γδ cells in the brain and alters resistant mice to susceptible-like phenotype. Am J Pathol 2001;158:163-172.
78. Mota M, Jarra W, Hirst E, Patnaik PK, Holder AA: Plasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific way. Infect Immun 2000;4135-4144.
79. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K: Intercellular adhesion molecule1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 1989;341:57-59.
80. Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ, Tachado SD: Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 1996;156:1897-1907.
81. Bondi FS: The incidence and outcome of neurological abnormalities in childhood cerebral malaria: A long term follow-up of 62 survivors. Trans R Soc Trop Med Hyg 1992;86:17-19.
82. Brewster DR, Kwiatkowski D, White NJ: Neurological sequelae of cerebral malaria in children. Lancet 1990;336:1039-1043.
83. Holding PA, Stevenson J, Peshu N: Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg 1999;93:529-534.
84. Clark IA, Rockett KA, Cowden WB: Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992;894-896.
85. Al Yaman FM, Mokela D, Genton B, Rockett KA, Alpers MP, Clark IA: Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 1996;90:270-273.
86. Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arenelle DR, Hollis D, McDonald MI, Granger DL: Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitricoxidesynthase type2 expression. J Exp Med 1996;184:557-567.
87. Bohme GA, Bon C, Lemaire M, Reibaud M, Piot O, Statzmann JM, Doble A, Blanchard JL: Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci USA 1993;90:9191-9194.
88. Daniel H, Hemart N, Jaillard D, Crepel F: Long-term depression requires nitric oxide and guanosine 3′:5′ cyclic monophosphate production in rat cerebellar Purkinje cells. Eur J Neurosci 1993;5:1079-1082.
89. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MS: Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 1994;163:973-977.
90. Rockett KA, Kwiatkowski D, Bate CA, Awburn MM, Rockett EJ, Clark IA: In vitro induction of nitric oxide by an extract of Plasmodium falciparum. J Infect 1996;32:187-196.
91. Tachado SD, Gerold P, Schwarz R, Novakovic S, McConville M, Schofield L: Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: Activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol. Proc Natl Acad Sci USA 1996;94:4022-4027.
92. Manzoni OL, Prezeau P, Marin P, Desharger S, Bockaert J, Fagni L: Nitric oxide-induced blockade of NMDA receptors. Neuron 1992;8:653-662.
93. Lei SZ, Pan ZH, Aggarwal SK, Chen HS, Hartman VJ, Sucher NJ, Lipton SA: Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 1992;8:1087-1099.
94. Lovinger DM, White G, Weight FF: Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989;243:1721-1724.
95. Puil E, El-Beheiry H, Baimbridge KG: Anaesthetic effects on glutamate-stimulated increase in intraneuronal calcium. J Pharmacol Exp Ther 1990;255:955-961.
96. Bianchi M, Battistin T, Galzigna L: 2,6-Diisopropylphenol, a general anesthetic, inhibits glutamate action on rat synaptosomes. Neurochem Res 1991;16:443-446.
97. Carla V, Moroni F: General anaesthestics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neurosci Lett 1992;146:21-24.
98. 45Ca uptake by rat brain microvesicles. Neurochem Res 1994;19:1515-1520.
99. Anonymous: Memorandum 24 on Medical Diseases in Tropical and Sub-Tropical Areas. London, War Office, 1942.
100. Clark IA, Rockett KA, Cowden WB: Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol Today 1991;7:205-207.
101. Chouchakova N, Skokowa J, Baumann U, Tscherning T, Phillippens KMH, Nieswandt B, Schmidt RE, Gessner JE: FcγRIII-mediated production of TNF-α induces immune complex alveolitis independently of CXC chemokine generation. J Immunol 2001;166:5193-5200.
102. Maeno Y, Perlmann P, Perlmann H, Kusuhara Y, Taniguchi K, Nakabayashi T, Win K, Looareesuwan S, Aikawa M: IgE deposition in brain microvessels and on parasitized erythrocytes from cerebral malaria patients. Am J Trop Med Hyg 2000;63:128-132.
103. Borish L, Mascali JJ, Rosenwasser LJ: IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J Immunol 1991;146:63-67.
104. Jakobsen PH, Bate CA, Taverne J, Playfair JH: Malaria: Toxins, cytokines and disease. Parasite Immunol 1995;17:223-231.
105. Kwiatkowski D: Malarial toxins and the regulation of parasite density. Parasitol Today 1995;11:206-212.
106. McConville MJ, Ferguson MAJ: The structure, biosynthesis, and function of glycosylated phosphatidylinositols in the parasite protozoa, higher eukaryotes (review). Biochem J 1993;294:305-324.
107. Englund PT: The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors. Annu Rev Biochem 1993;62:121-138.
108. Ferguson MAJ, Brimacombe JS, Brown JR, Crossman A, Dix A, Field RA, Guther ML, Milne KG, Sharma DK, Smith TK: The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness. Biochim Biophys Acta 1999;1455:327-340.
109. Naik RS, Branch OH, Woods AS, Vijaykumar M, Perkins DJ, Nahlen BL, Lal AA, Cotter RJ, Costello CE, Ockenhouse CF, Davidson EA, Gowda DC: Glycosylphosphatidyhnositol anchors of Plasmodium falciparum. Molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med 2000;192:1563-1576.
110. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN: Dynamics of fever and serum levels of TNF are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992;89:3200-3203.
111. Bate CA, Taverne J, Playfair JHL: Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology 1990;70:315-320.
112. Ghigo D, Todde R, Ginsburg H, Costamagna C, Gautret P, Bussolino F, Ulliers D, Giribaldi G, Deharo E, Gabrielli G, et al: Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release of NOS-inducing soluble factor. J Exp Med 1995;182:677-688.
113. Desowitz RS, Elm J, Alpers MP: Plasmodium falciparum-specific immunoglobulin G(IgG), IgM, and IgE antibodies in paired maternalcord serum from East Sepik Province, Papua New Guinea. Infect Immun 1993;61:988-993.
114. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P: Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990;172:1633-1641.
115. Bouharoun-Tayoun H, Druilhe P: Plasmodium falciparum malaria: Evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 1992;60:1473-1481.
116. Maeno Y, Steketee RW, Nagatake T: Immunoglobulin complex deposits in Plasmodium falciparum-infected placentas from Malawi and Papua New Guinea. Am J Trop Med Hyg 1993;49:574-580.
117. Czermak BJ, Sarma V, Blell NM, Schmal H, Friedl HP, Ward PA: In vitro and in vivo dependency of chemokine generation on C5a and TNF-α. J Immunol 1996;162:2321.
118. Ward PA: Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann NY Acad Sci 1996;796:104-112.
119. Udomsangpetch R, Chivapat S, Viriyavejkul P, Riganti M, Wilairatana P, Pongponratin E, Looareesuwan S: Involvement of cytokines in the histopathology of cerebral malaria. Am J Trop Med Hyg 1997;57:501-506.
120. Clark IA, Awburn MM, Whitten RO, Harper CG, Liomba NG, Molyneux EM, Taylor TE: Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malar J 2003;2:6.
121. Pino P, Vouldoukis I, Dugas N, Hassani-Loppion G, Dugas B, Mazier D: Redox-dependent apoptosis in human endothelial cells after adhesion of Plasmodium falciparum-infected erythrocytes. Ann NY Acad Sci 2003;1010:582-586.
122. Wang JM, Walter S, Mantovani A: Re-evaluation of the chemotactic activity of tumor necrosis factor for monocytes. Immunology 1990;71:364-367.
123. Vassalli P: The pathophysiology of tumor necrosis factors (review). Annu Rev Immunol 1992;10:411-452.
124. Verhoeven AJ, Bolscher BGJM, Roos D: The superoxide generating enzyme in phagocytes: Physiology, protein composition, and mechanism of activation; in Pelfrey C (ed): Membrane Lipid Oxidation. . Boston, CRC Press, 1991, pp 42-59.
125. Mohan K, Dubey ML, Ganguly NK, Mahajan RC: Plasmodium falciparum: Role of activated blood monocytes in erythrocyte damage and red cell loss during malaria. Exp Parasitol 1995;80:54-63.
126. Allison AC, Eugui EM: A radical interpretation of immunity to malaria parasites. Lancet 1982;i:1431-1433.
127. Mohan K, Dubey ML, Ganguly NK, Mahajan RC: Plasmodium falciparum induced perturbations of the erythrocyte antioxidant system. Clin Chim Acta 1992;209:19-26.
128. Mohan K, Ganguly NK, Dubey ML, Mahajan RC: Oxidative damage of erythrocytes infected with Plasmodium falciparum: An in vitro study. Ann Haemotol 1992;65:131-134.
129. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumar V: A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 1999;179:279-282.
130. May J, Lell B, Luty AJF, Meyer CG, Kremsner PG: Plasma interleukin-10:tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis 2000;182:1570-1573.
131. Kossodo S, Monso C, Juillard P, Velu T, Goldman M, Grau GE: Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 1997;91:536-540.
132. Linke A, Kuhn R, Muller W, Honarvar N, Li C, Langhorne J: Plasmodium chabaudi chabaudi: Differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol 1996;84:253-263.
133. Li C, Corraliza I, Langhorne J: A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect Immun 1999;67:4435-4442.
134. Wahl SM: Transforming growth factor beta: The good, the bad, and the ugly. J Exp Med 1994;180:1587-1590.
135. Li C, Sanni LA, Omer F, Riley E, Langhorne J: Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies. Infect Immun 2003;71:4850-4856.
136. Omer FM, Riley EM: Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J Exp Med 1998;188:39-48.
137. Perkins DJ, Weinberg JB, Kremsner PG: Reduced interleukin-12 and transforming growth factor-β1 in severe childhood malaria: Relationship of cytokine balance with disease severity. J Infect Dis 2000;182:988-992.
138. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Duombo OK, Sztein MB: Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 2004;72:5630-5637.
139. Esamai F, Ernerudh J, Janols H, Welin S, Ekerfelt C, Mining S, Forsberg P: Cerebral malaria in children: Serum and cerebrospinal fluid TNF-alpna and TGF-beta levels and their relationship to clinical outcome. J Trop Pediatr 2003;49:216-223.
140. Bogdan C, Paik J, Vodokvotz Y, Nathan C: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 1992;267:23301-23308.
141. Hermans IF, Ritchie DS, Yang J, Roberts JM, Ronchese F: CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol 2000;164:3095-3101.
142. Kedl RM, Schaefer BC, Kappler JW, Marrack P: T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat Immunol 2000;3:27-32.
143. Hafalla JCR, Morrot A, Sano G, Milon G, Lafaille JJ, Zavala F: Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria. J Immunol 2003;171:964-970.
144. Carvalho LH, Sano G, Hafalla JCR, Morrot A, Curotto de Lafaille MA, Zavala F: IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T cell responses against malaria liver stages. Nat Med 2002;8:166-170.
145. White NJ, Warell DA: Pathophysiological and prognostic significance of cerebrospinal fluid lactate in cerebral malaria. Lancet 1985;i:776-778.
146. Krishna S, Waller DW, ter Kuile F, Kwiatkowski D, Crawly J, Craddock CF, Nosten F, Chapmann D, Brewster D, Holloway PA, White NJ: Lactic acidosis and hypoglycaemia in children with severe malaria: Pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg 1994;88:67-73.
147. Krishna S, Agbenyega T, Angus BJ, BeduAddo G, Ofori-Amanfo G, Henderson G, Szwandt IS, O'Brien R, Stacpoole PW: Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria. Q J Med 1995;88:341-349.
148. Phillips RE, Looareesuwan S, Molyneux ME, Hatz C, Warrel DA: Hypoglycaemia and counterregulatory hormone responses in severe falciparum malaria-treatment with Sandostatin. Q J Med 1993;71:477-483.
149. Curtis SE, Cain SM: Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. Am Rev Respir Dis 1992;145:348-354.
150. 2 in endotoxemic dogs during shock and resuscitation. J Appl Physiol 1994;76:793-800.
151. Hayano Y: Influence of induced hyperthermia on intestinal blood flow, translocation of endotoxin and other factors in mongrel dogs (in Japanese). Masui 1991;40:769-781.
152. Hotchkiss RS, Karl IE: Re-evaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992;267:1503-1510.
153. 18F] fluoromisonidazole. Am J Physiol 1991;261:R965-R972.
154. Warrel DA: Pathophysiology of severe falciparum malaria in man. Parasitology 1987;94:S53-S76.
155. Elased K, Desouza J, Playfair JHL: Blood-stage malaria infection in diabetic mice. Clin Exp Immunol 1995;99:440-444.
156. Elased K, Playfair JHL: Hypoglycemia and hyperinsulinemia in rodent models of severe malaria infection. Infect Immun 1994;62:5157-5160.
157. Taylor TE, Molyneux ME, Wirima JJ, Fletcher KA, Morris K: Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N Engl J Med 1988;319:1040-1047.
158. Clark IA, Rockett KA: Nitric oxide and parasitic disease (review). Adv Parasitol 1996;37:1-56.
159. Starnes HF, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W: Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 1988;82:1312-1325.
160. Elased KM, Gumaa KA, de Souza JB, Rahmoune H, Playfair JH, Rademacher T: Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs). Mol Genet Metab 2001;73:248-258.
161. Brass EP, Vetter WH: Inhibition of glucagon-stimulated glycogenolysis by S-nitroso-N-acetylpenicillamine. Pharmacol Toxicol 1993;72:369-372
162. Horton RA, Knowles RG, Titheradge MA: Endotoxin causes reciprocal changes in hepatic nitric oxide synthesis, gluconeogenesis, and flux through phosphoenolpyruvate carboxykinase. Biochem Biophys Res Commun 1994;204:659-665.
163. Molina y Vedia L, McDonald B, Reep B, Brune B, Di Silvio M, Billiar T, Lapetina EG: Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem 1992;267:24929-24932.
164. Benigni F, Atsumi T, Calandra T, Metz C, Echtenacher B, Peng T, Bucala R: The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism m muscle. J Clin Invest 2000;106:1291-1300.
165. Calandra T, Bucala R: Macrophage migratory inhibitory factor - A counter-regulator of glucocorticoid and critical mediator of septic shock. J Inflamm 1996;47:39-51.
166. McDevitt M A, Xie J, Gordeuk V, Bucala R: The anemia of malaria infection: Role of inflammatory cytokines. Curr Hematol Rep 2004;3:97-106.